Search Results - Eric L. Simpson

Refine Results
  1. 1

    Acitretin therapy for Galli-Galli disease by Chandler W. Rundle, MD, Solveig Ophaug, MD, Eric L. Simpson, MD, MCR

    Published in JAAD Case Reports (2020-05-01)
    Get full text
    Article


  2. 2

    Publisher Correction to: Real-World Effectiveness of Dupilumab in Adult and Adolescent Patients with Atopic Dermatitis: 2-Year Interim Data from the PROSE Registry by Eric L. Simpson, Ben Lockshin, Lara Wine Lee, Zhen Chen, Moataz Daoud, Andrew Korotzer

    Published in Dermatology and Therapy (2024-04-01)
    Get full text
    Article


  3. 3

    Real-World Effectiveness of Dupilumab in Adult and Adolescent Patients with Atopic Dermatitis: 2-Year Interim Data from the PROSE Registry by Eric L. Simpson, Ben Lockshin, Lara Wine Lee, Zhen Chen, Moataz Daoud, Andrew Korotzer

    Published in Dermatology and Therapy (2024-01-01)
    Get full text
    Article


  4. 4

    Ruxolitinib Cream in Adolescents/Adults with Atopic Dermatitis Meeting Severity Thresholds for Systemic Therapy: Exploratory Analysis of Pooled Results from Two Phase 3 Studies by Eric L. Simpson, Leon Kircik, Andrew Blauvelt, Howard Kallender, Daniel Sturm, Mingyue Wang, Lawrence F. Eichenfield

    Published in Dermatology and Therapy (2024-07-01)
    Get full text
    Article


  5. 5

    Abrocitinib 100 mg Once Daily for Moderate-to-Severe Atopic Dermatitis: A Review of Efficacy and Safety, and Expert Opinion on Use in Clinical Practice by Melinda J. Gooderham, Andrew E. Pink, Eric L. Simpson, Jonathan I. Silverberg, Erman Güler, Melissa Watkins

    Published in Dermatology and Therapy (2023-07-01)
    Get full text
    Article


  6. 6

    Switching from Dupilumab to Abrocitinib in Patients With Moderate-to-Severe Atopic Dermatitis: A Post Hoc Analysis of Efficacy After Treatment With Dupilumab in JADE DARE by Jonathan I. Silverberg, Eric L. Simpson, Andrew E. Pink, Stephan Weidinger, Gary Chan, Pinaki Biswas, Claire Clibborn, Erman Güler

    Published in Dermatology and Therapy (2025-02-01)
    Get full text
    Article


  7. 7

    Ruxolitinib cream monotherapy demonstrates rapid improvement in the extent and signs of mild to moderate atopic dermatitis across head and neck and other anatomic regions in adoles... by Eric L. Simpson, Robert Bissonnette, Zelma C. Chiesa Fuxench, Howard Kallender, Daniel Sturm, Haobo Ren, Linda F. Stein Gold

    Published in Journal of Dermatological Treatment (2024-12-01)
    Get full text
    Article


  8. 8

    Disease burden among patients with atopic dermatitis treated with systemic therapy for 4–12 months: results from the CorEvitas Atopic Dermatitis Registry by Jonathan I. Silverberg, Evangeline Pierce, Meghan Feely, Amber Reck Atwater, Amy Schrader, Eric A. Jones, Swapna S. Dave, Eric L. Simpson

    Published in Journal of Dermatological Treatment (2023-12-01)
    Get full text
    Article


  9. 9

    Emollient use alters skin barrier and microbes in infants at risk for developing atopic dermatitis. by Martin Glatz, Jay-Hyun Jo, Elizabeth A Kennedy, Eric C Polley, Julia A Segre, Eric L Simpson, Heidi H Kong

    Published in PLoS ONE (2018-01-01)
    Get full text
    Article


  10. 10

    Crisaborole Ointment Improves Quality of Life of Patients with Mild to Moderate Atopic Dermatitis and Their Families by Eric L. Simpson, Amy S. Paller, Mark Boguniewicz, Lawrence F. Eichenfield, Steven R. Feldman, Jonathan I. Silverberg, Sarah L. Chamlin, Lee T. Zane

    Published in Dermatology and Therapy (2018-10-01)
    Get full text
    Article


  11. 11

    Eosinophils increase neuron branching in human and murine skin and in vitro. by Erin L Foster, Eric L Simpson, Lorna J Fredrikson, James J Lee, Nancy A Lee, Allison D Fryer, David B Jacoby

    Published in PLoS ONE (2011-01-01)
    Get full text
    Article


  12. 12

    Clinically Meaningful Improvements in Adolescents with Moderate-to-Severe Atopic Dermatitis Treated with Tralokinumab who did not Achieve Clear or Almost Clear Skin at Week 16 by Amy S. Paller, Andrew Blauvelt, Weily Soong, H. Chih-ho Hong, Marie L. A. Schuttelaar, Shannon K. R. Schneider, Eric L. Simpson

    Published in Dermatology and Therapy (2025-07-01)
    Get full text
    Article


  13. 13

    Restoring balance in atopic disorders: insights into type 2 immunity and chronic inflammation by Eric L. Simpson, Oscar Palomares, Brian S. Kim, Klaus F. Rabe, Klaus F. Rabe, Yamo Deniz, Antonio Martin, Rahin Ghassemebrahimzadeh, Sonya L. Cyr

    Published in Frontiers in Immunology (2026-06-01)
    Get full text
    Article


  14. 14

    Tapinarof Improved Outcomes and Sleep for Patients and Families in Two Phase 3 Atopic Dermatitis Trials in Adults and Children by Eric L. Simpson, Adelaide A. Hebert, John Browning, Rocco T. Serrao, Howard Sofen, Philip M. Brown, Stephen C. Piscitelli, David S. Rubenstein, Anna M. Tallman

    Published in Dermatology and Therapy (2025-01-01)
    Get full text
    Article


  15. 15

    Correction to: Qualitative Assessment of Adult Patients’ Perception of Atopic Dermatitis Using Natural Language Processing Analysis in a Cross-Sectional Study by Bruno Falissard, Eric L. Simpson, Emma Guttman-Yassky, Kim A. Papp, Sebastien Barbarot, Abhijit Gadkari, Grece Saba, Laurene Gautier, Adeline Abbe, Laurent Eckert

    Published in Dermatology and Therapy (2020-03-01)
    Get full text
    Article


  16. 16

    Qualitative Assessment of Adult Patients’ Perception of Atopic Dermatitis Using Natural Language Processing Analysis in a Cross-Sectional Study by Bruno Falissard, Eric L. Simpson, Emma Guttman-Yassky, Kim A. Papp, Sebastien Barbarot, Abhijit Gadkari, Grece Saba, Laurene Gautier, Adeline Abbe, Laurent Eckert

    Published in Dermatology and Therapy (2020-01-01)
    Get full text
    Article


  17. 17

    Efficacy and safety of abrocitinib in patients with moderate‐to‐severe atopic dermatitis with prior exposure to oral systemic immunosuppressants or biologic therapies: A post hoc a... by Melinda J. Gooderham, Michael R. Ardern‐Jones, Emma Guttman‐Yassky, Mahreen Ameen, Eric L. Simpson, Gary Chan, Pinaki Biswas, Wing S. Chiu, Melissa Watkins

    Published in JEADV Clinical Practice (2023-12-01)
    Get full text
    Article


  18. 18

    Benefit–risk profile comparison between dupilumab and upadacitinib: a structured benefit–risk assessment of the Heads Up trial by Andrew Blauvelt, Eric L. Simpson, Kilian Eyerich, Marjolein de Bruin-Weller, Sebastien Barbarot, Peter A. Lio, William Hurst, Stephanie Tcherny-Lessenot, Stephane Levy, Mike Bastian

    Published in Journal of Dermatological Treatment (2026-12-01)
    Get full text
    Article


  19. 19

    Responder Threshold for Patient-Oriented Eczema Measure (POEM) and Children’s Dermatology Life Quality Index (CDLQI) in Adolescents with Atopic Dermatitis by Eric L. Simpson, Marjolein de Bruin-Weller, Laurent Eckert, Diane Whalley, Isabelle Guillemin, Matthew Reaney, Zhen Chen, Lauren Nelson, Shanshan Qin, Ashish Bansal, Abhijit Gadkari

    Published in Dermatology and Therapy (2019-10-01)
    Get full text
    Article


  20. 20

    Practical Management of the JAK1 Inhibitor Abrocitinib for Atopic Dermatitis in Clinical Practice: Special Safety Considerations by Melinda J. Gooderham, Marjolein de Bruin-Weller, Stephan Weidinger, Michael J. Cork, Lawrence F. Eichenfield, Eric L. Simpson, Athanasios Tsianakas, Urs Kerkmann, Claire Feeney, William Romero

    Published in Dermatology and Therapy (2024-07-01)
    Get full text
    Article


Search Tools: